Figure 3.
Fibrinogen contribution of clot strength between control and TEG-guided prophylaxis groups. There is a trend toward a decreased fibrinogen contribution to clot strength in the TEG-guided prophylaxis group on study days 2 through 4, suggesting that additional LMWH may decrease the fibrinogen contribution to clot strength. The overall difference between groups was not significant using repeated measures ANOVA.